ClearSeq Cancer is a comprehensive next generation sequencing target enrichment panel designed specifically for genetic anomalies in known cancer hotspots. This NGS application targets a set of 47 genes found in previous research to be associated with a broad range of cancer types as well as with published drug targets. The COSMIC database was the primary reference in the design process.Compatible with HaloPlexHS and HaloPlex Target Enrichment System
ClearSeq Cancer is uniquely suited for high performance with cancer research samples, which are commonly preserved as formalin fixed and paraffin embedded (FFPE). This FFPE process often results in highly fragmented DNA, resulting in insufficient sequencing target coverage. FFPE also commonly produces small changes in single bases, cytosine to thymine, in DNA sequences. Unlike competitive technologies, HaloPlex covers each base with several amplicons, and smaller fragments function as a backup for longer fragments that may fail. This allows for high sequencing target coverage even in highly degraded FFPE samples.
貨號 | 產品 | 數量 | |
---|---|---|---|
G9933A | ClearSeq Cancer, HS, ILM | 16 rxns | |
G9933B | ClearSeq Cancer, HS, ILM | 96 rxns | |
G9903A | ClearSeq Cancer, ILM | 16 rxns | |
G9903B | ClearSeq Cancer, ILM | 96 rxns | |
G9934A | ClearSeq Cancer, HS, ION | 16 rxns | |
G9934B | ClearSeq Cancer, HS, ION | 96 rxns | |
G9904A | ClearSeq Cancer, ION | 16 rxns | |
G9904B | ClearSeq Cancer, ION | 96 rxns |